Clinical trial
Gene Therapy in HIV-Positive Patients With Non-Hodgkin's Lymphoma
NCT00002221 · Ribozyome, Industry · Completed
Key facts
| NCT number | NCT00002221 |
|---|---|
| Title | Gene Therapy in HIV-Positive Patients With Non-Hodgkin's Lymphoma |
| Official title | High Dose Chemotherapy and Autologous Peripheral Stem Cell Transplantation for HIV Lymphomas: A Phase IIA Study of Comparative Marking Using a Ribozyme Gene and a Neutral Gene |
| Lead sponsor | Ribozyome, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma, Non-Hodgkin, HIV Infections |
| Intervention type | Drug |
| Interventions | Peripheral blood stem cells |
| Enrollment | 5 |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: